Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Eligibility

Organization's Location
incididunt elit
Program Location
aute
Organization Type
up to 2.5M

Submission

Schedule
Step 1: voluptate laborum proident
Application deadline
Oct 18, 2024
Step 2: eiusmod quis (cupidatat nisi)

Similar grants